Page last updated: 2024-08-25

dexrazoxane and Fibrosarcoma

dexrazoxane has been researched along with Fibrosarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, S; Fuhrmann, D; Gödtel-Armbrust, U; Kaina, B; Nemecek, A; Nikolova, T; Wojnowski, L; Yan, T1

Other Studies

1 other study(ies) available for dexrazoxane and Fibrosarcoma

ArticleYear
The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
    British journal of pharmacology, 2015, Volume: 172, Issue:9

    Topics: Activating Transcription Factor 3; Antigens, Neoplasm; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Line, Tumor; Dexrazoxane; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Fibrosarcoma; Histones; Humans; Intracellular Signaling Peptides and Proteins; Poly-ADP-Ribose Binding Proteins; RNA Interference; Signal Transduction; Time Factors; Topoisomerase II Inhibitors; Transfection; Tumor Suppressor p53-Binding Protein 1; Tumor Suppressor Protein p53

2015